- Description
- Table of Contents
- Request Sample
The Global Cancer Diagnostic Devices market is expected to reach $34.06 billion by 2027 growing at a CAGR of 14.5% during 2020 to 2027. Diagnostic devices are used to identify the nature or cause of certain phenomenon, generally related to a medical condition and cancer diagnostic devices are devices used to identify the nature and cause of cancer. Biospecies provide required information to diagnose cancer but, because of their invasiveness, they are difficult to use for managing cancer therapy. Factors such as the increasing incidence of cancer and the need for cost-cutting by pharma companies are driving the market growth. Though, the high cost of diagnostic imaging systems is restraining the market. Growing focus on personalized medicine is the opportunity for the cancer diagnostic devices market. Based on product type, the proteomics segment is anticipated to grow at a significant rate during the forecast period. Proteomics is the use of quantitative protein-level measurements of gene expression to characterize biological processes such as disease processes and drug effects and decipher the mechanism of gene expression control. The key vendors mentioned are Abbott Diagnostics, Affymetrix, Agilent Technologies, Ambry Genetics, Annoroad, Aviva Biosciences, BD, BioMérieux, Bio-Rad, DiagnoCure, Epic Sciences, Epigenonics, Genomic Health, HalioDX, Myriad Genetics, Qiagen, Roche Diagnostics, Thermo Fisher Scientific, Ventana Medical Systems, and Vysis. Product Types Covered: • Molecular Diagnostics • Companion Diagnostics • Genomics • Proteomics • Metabolomics • Epigenetics Technology Types Covered: • Instrument-Based • Platform-Based Diagnostics • Tumor Biomarkers Tests End Users Covered: • Hospital • Clinic Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2019 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cancer Diagnostic Devices Market, By Product Type
5.1 Introduction
5.2 Molecular Diagnostics
5.3 Companion Diagnostics
5.4 Genomics
5.5 Proteomics
5.6 Metabolomics
5.7 Epigenetics
6 Global Cancer Diagnostic Devices Market, By Technology Type
6.1 Introduction
6.2 Instrument-Based
6.3 Platform-Based Diagnostics
6.4 Tumor Biomarkers Tests
7 Global Cancer Diagnostic Devices Market, By End User
7.1 Introduction
7.2 Hospital
7.3 Clinic
8 Global Cancer Diagnostic Devices Market, By Geography
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 South America
8.6 Middle East & Africa
9 Strategic Benchmarking
10 Vendors Landscape
10.1 Abbott Diagnostics
10.2 Affymetrix
10.3 Agilent Technologies
10.4 Ambry Genetics
10.5 Annoroad
10.6 Aviva Biosciences
10.7 BD
10.8 BioMérieux
10.9 Bio-Rad
10.10 DiagnoCure
10.11 Epic Sciences
10.12 Epigenonics
10.13 Genomic Health
10.14 HalioDX
10.15 Myriad Genetics
10.16 Qiagen
10.17 Roche Diagnostics
10.18 Thermo Fisher Scientific
10.19 Ventana Medical Systems
10.20 Vysis
List of Data Tables
1 Global Cancer Diagnostic Devices Market Outlook, By Region (2019-2027) ($MN)
2 Global Cancer Diagnostic Devices Market Outlook, By Product Type (2019-2027) ($MN)
3 Global Cancer Diagnostic Devices Market Outlook, By Molecular Diagnostics (2019-2027) ($MN)
4 Global Cancer Diagnostic Devices Market Outlook, By Companion Diagnostics (2019-2027) ($MN)
5 Global Cancer Diagnostic Devices Market Outlook, By Genomics (2019-2027) ($MN)
6 Global Cancer Diagnostic Devices Market Outlook, By Proteomics (2019-2027) ($MN)
7 Global Cancer Diagnostic Devices Market Outlook, By Metabolomics (2019-2027) ($MN)
8 Global Cancer Diagnostic Devices Market Outlook, By Epigenetics (2019-2027) ($MN)
9 Global Cancer Diagnostic Devices Market Outlook, By Technology Type (2019-2027) ($MN)
10 Global Cancer Diagnostic Devices Market Outlook, By Instrument-Based (2019-2027) ($MN)
11 Global Cancer Diagnostic Devices Market Outlook, By Platform-Based Diagnostics (2019-2027) ($MN)
12 Global Cancer Diagnostic Devices Market Outlook, By Tumor Biomarkers Tests (2019-2027) ($MN)
13 Global Cancer Diagnostic Devices Market Outlook, By End User (2019-2027) ($MN)
14 Global Cancer Diagnostic Devices Market Outlook, By Hospital (2019-2027) ($MN)
15 Global Cancer Diagnostic Devices Market Outlook, By Clinic (2019-2027) ($MN)
16 North America Cancer Diagnostic Devices Market Outlook, By Product Type (2019-2027) ($MN)
17 North America Cancer Diagnostic Devices Market Outlook, By Technology Type (2019-2027) ($MN)
18 North America Cancer Diagnostic Devices Market Outlook, By End User (2019-2027) ($MN)
19 Europe Cancer Diagnostic Devices Market Outlook, By Product Type (2019-2027) ($MN)
20 Europe Cancer Diagnostic Devices Market Outlook, By Technology Type (2019-2027) ($MN)
21 Europe Cancer Diagnostic Devices Market Outlook, By End User (2019-2027) ($MN)
22 Asia Pacific Cancer Diagnostic Devices Market Outlook, By Product Type (2019-2027) ($MN)
23 Asia Pacific Cancer Diagnostic Devices Market Outlook, By Technology Type (2019-2027) ($MN)
24 Asia Pacific Cancer Diagnostic Devices Market Outlook, By End User (2019-2027) ($MN)
25 South America Cancer Diagnostic Devices Market Outlook, By Product Type (2019-2027) ($MN)
26 South America Cancer Diagnostic Devices Market Outlook, By Technology Type (2019-2027) ($MN)
27 South America Cancer Diagnostic Devices Market Outlook, By End User (2019-2027) ($MN)
28 Middle East & Africa Cancer Diagnostic Devices Market Outlook, By Product Type (2019-2027) ($MN)
29 Middle East & Africa Cancer Diagnostic Devices Market Outlook, By Technology Type (2019-2027) ($MN)
30 Middle East & Africa Cancer Diagnostic Devices Market Outlook, By End User (2019-2027) ($MN)